Helicobacter pylori eradication : influence of interleukin-1beta –31 C/T polymorphism

Bibliographic Details
Main Author: Rech, Tássia Flores
Publication Date: 2018
Other Authors: Mazzoleni, Luiz Edmundo, Mazzoleni, Felipe, Francesconi, Carlos Fernando de Magalhães, Sander, Guilherme Becker, Michita, Rafael Tomoya, Nabinger, Débora Dreher, Milbradt, Tobias Cancian, Torresini, Ronaldo Joao Spinato, Simon, Daniel
Format: Article
Language: eng
Source: Repositório Institucional da UFRGS
Download full: http://hdl.handle.net/10183/200264
Summary: Aim: To analyze the influence of the –31 C/T polymorphism of the interleukin-1 gene on Helicobacter pylori eradication therapy success in patients with functional dyspepsia. Methods: Functional dyspepsia was diagnosed according to the Rome III criteria. All patients underwent upper gastrointestinal endoscopy, and gastric biopsies were obtained at screening and 12 months after randomization (last follow-up visit). Urease test and histological examination were performed to define the H. pylori status. Patients received twice-daily amoxicillin, clarithromycin and omeprazole for 10 days. Genotyping of the interleukin-1beta –31 C/T polymorphism (rs1143627)was performed using polymerase chain reaction-restriction fragment length polymorphism. Results: One hundred forty-nine patients received treatment with triple therapy for H. pylori eradication. Only one patient was lost to follow-up, and adherence to study medication was 94.6%. A total of 148 patients (mean age 46.08±12.24 years; 81.8% women) were evaluated for the influence of the interleukin-1beta –31 C/T polymorphism on the outcome of H. pylori eradication therapy. After treatment, bacteria were eradicated in 87% of patients (129/148). Genotype frequencies of the polymorphism were as follows: CC, 38/148 (25.7%); CT, 71/148 (47.9%); and TT, 39/148 (26.4%). Successful eradication rate was 78.9%, 94.4% and 82.1% for the CC, CT and TT genotypes, respectively. The CT genotype was significantly associated with successful H. pylori eradication (p = 0.039). Conclusion: This study suggests that the CT genotype of the interleukin-1beta –31 C/T polymorphism plays a role in the successful eradication of H. pylori among patients with functional dyspepsia.
id UFRGS-2_c7b923f45ca6a2c4887fc33e43b49721
oai_identifier_str oai:www.lume.ufrgs.br:10183/200264
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Rech, Tássia FloresMazzoleni, Luiz EdmundoMazzoleni, FelipeFrancesconi, Carlos Fernando de MagalhãesSander, Guilherme BeckerMichita, Rafael TomoyaNabinger, Débora DreherMilbradt, Tobias CancianTorresini, Ronaldo Joao SpinatoSimon, Daniel2019-10-09T03:47:41Z20181413-8670http://hdl.handle.net/10183/200264001079196Aim: To analyze the influence of the –31 C/T polymorphism of the interleukin-1 gene on Helicobacter pylori eradication therapy success in patients with functional dyspepsia. Methods: Functional dyspepsia was diagnosed according to the Rome III criteria. All patients underwent upper gastrointestinal endoscopy, and gastric biopsies were obtained at screening and 12 months after randomization (last follow-up visit). Urease test and histological examination were performed to define the H. pylori status. Patients received twice-daily amoxicillin, clarithromycin and omeprazole for 10 days. Genotyping of the interleukin-1beta –31 C/T polymorphism (rs1143627)was performed using polymerase chain reaction-restriction fragment length polymorphism. Results: One hundred forty-nine patients received treatment with triple therapy for H. pylori eradication. Only one patient was lost to follow-up, and adherence to study medication was 94.6%. A total of 148 patients (mean age 46.08±12.24 years; 81.8% women) were evaluated for the influence of the interleukin-1beta –31 C/T polymorphism on the outcome of H. pylori eradication therapy. After treatment, bacteria were eradicated in 87% of patients (129/148). Genotype frequencies of the polymorphism were as follows: CC, 38/148 (25.7%); CT, 71/148 (47.9%); and TT, 39/148 (26.4%). Successful eradication rate was 78.9%, 94.4% and 82.1% for the CC, CT and TT genotypes, respectively. The CT genotype was significantly associated with successful H. pylori eradication (p = 0.039). Conclusion: This study suggests that the CT genotype of the interleukin-1beta –31 C/T polymorphism plays a role in the successful eradication of H. pylori among patients with functional dyspepsia.application/pdfengThe Brazilian journal of infectious diseases. Vol. 22, no. 4 (Jul./Aug. 2018), p. 311-316DispepsiaHelicobacter pyloriInterleucina-1betaPolimorfismo genéticoHelicobacter pyloriDyspepsiaInterleukin-1betaHelicobacter pylori eradication : influence of interleukin-1beta –31 C/T polymorphisminfo:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001079196.pdf.txt001079196.pdf.txtExtracted Texttext/plain28356http://www.lume.ufrgs.br/bitstream/10183/200264/2/001079196.pdf.txt7b2bdf92a1fae3cbcfe285ff1e44ecfcMD52ORIGINAL001079196.pdfTexto completo (inglês)application/pdf316284http://www.lume.ufrgs.br/bitstream/10183/200264/1/001079196.pdf8f971ced83b1c3877fd2e8b2aedc046dMD5110183/2002642023-05-27 03:44:09.048841oai:www.lume.ufrgs.br:10183/200264Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2023-05-27T06:44:09Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Helicobacter pylori eradication : influence of interleukin-1beta –31 C/T polymorphism
title Helicobacter pylori eradication : influence of interleukin-1beta –31 C/T polymorphism
spellingShingle Helicobacter pylori eradication : influence of interleukin-1beta –31 C/T polymorphism
Rech, Tássia Flores
Dispepsia
Helicobacter pylori
Interleucina-1beta
Polimorfismo genético
Helicobacter pylori
Dyspepsia
Interleukin-1beta
title_short Helicobacter pylori eradication : influence of interleukin-1beta –31 C/T polymorphism
title_full Helicobacter pylori eradication : influence of interleukin-1beta –31 C/T polymorphism
title_fullStr Helicobacter pylori eradication : influence of interleukin-1beta –31 C/T polymorphism
title_full_unstemmed Helicobacter pylori eradication : influence of interleukin-1beta –31 C/T polymorphism
title_sort Helicobacter pylori eradication : influence of interleukin-1beta –31 C/T polymorphism
author Rech, Tássia Flores
author_facet Rech, Tássia Flores
Mazzoleni, Luiz Edmundo
Mazzoleni, Felipe
Francesconi, Carlos Fernando de Magalhães
Sander, Guilherme Becker
Michita, Rafael Tomoya
Nabinger, Débora Dreher
Milbradt, Tobias Cancian
Torresini, Ronaldo Joao Spinato
Simon, Daniel
author_role author
author2 Mazzoleni, Luiz Edmundo
Mazzoleni, Felipe
Francesconi, Carlos Fernando de Magalhães
Sander, Guilherme Becker
Michita, Rafael Tomoya
Nabinger, Débora Dreher
Milbradt, Tobias Cancian
Torresini, Ronaldo Joao Spinato
Simon, Daniel
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Rech, Tássia Flores
Mazzoleni, Luiz Edmundo
Mazzoleni, Felipe
Francesconi, Carlos Fernando de Magalhães
Sander, Guilherme Becker
Michita, Rafael Tomoya
Nabinger, Débora Dreher
Milbradt, Tobias Cancian
Torresini, Ronaldo Joao Spinato
Simon, Daniel
dc.subject.por.fl_str_mv Dispepsia
Helicobacter pylori
Interleucina-1beta
Polimorfismo genético
topic Dispepsia
Helicobacter pylori
Interleucina-1beta
Polimorfismo genético
Helicobacter pylori
Dyspepsia
Interleukin-1beta
dc.subject.eng.fl_str_mv Helicobacter pylori
Dyspepsia
Interleukin-1beta
description Aim: To analyze the influence of the –31 C/T polymorphism of the interleukin-1 gene on Helicobacter pylori eradication therapy success in patients with functional dyspepsia. Methods: Functional dyspepsia was diagnosed according to the Rome III criteria. All patients underwent upper gastrointestinal endoscopy, and gastric biopsies were obtained at screening and 12 months after randomization (last follow-up visit). Urease test and histological examination were performed to define the H. pylori status. Patients received twice-daily amoxicillin, clarithromycin and omeprazole for 10 days. Genotyping of the interleukin-1beta –31 C/T polymorphism (rs1143627)was performed using polymerase chain reaction-restriction fragment length polymorphism. Results: One hundred forty-nine patients received treatment with triple therapy for H. pylori eradication. Only one patient was lost to follow-up, and adherence to study medication was 94.6%. A total of 148 patients (mean age 46.08±12.24 years; 81.8% women) were evaluated for the influence of the interleukin-1beta –31 C/T polymorphism on the outcome of H. pylori eradication therapy. After treatment, bacteria were eradicated in 87% of patients (129/148). Genotype frequencies of the polymorphism were as follows: CC, 38/148 (25.7%); CT, 71/148 (47.9%); and TT, 39/148 (26.4%). Successful eradication rate was 78.9%, 94.4% and 82.1% for the CC, CT and TT genotypes, respectively. The CT genotype was significantly associated with successful H. pylori eradication (p = 0.039). Conclusion: This study suggests that the CT genotype of the interleukin-1beta –31 C/T polymorphism plays a role in the successful eradication of H. pylori among patients with functional dyspepsia.
publishDate 2018
dc.date.issued.fl_str_mv 2018
dc.date.accessioned.fl_str_mv 2019-10-09T03:47:41Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/other
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/200264
dc.identifier.issn.pt_BR.fl_str_mv 1413-8670
dc.identifier.nrb.pt_BR.fl_str_mv 001079196
identifier_str_mv 1413-8670
001079196
url http://hdl.handle.net/10183/200264
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv The Brazilian journal of infectious diseases. Vol. 22, no. 4 (Jul./Aug. 2018), p. 311-316
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/200264/2/001079196.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/200264/1/001079196.pdf
bitstream.checksum.fl_str_mv 7b2bdf92a1fae3cbcfe285ff1e44ecfc
8f971ced83b1c3877fd2e8b2aedc046d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1798487414250930176